Literature DB >> 3434236

Ocular hypertension. A prospective twenty-year follow-up study.

L Lundberg1, K Wettrell, E Linnér.   

Abstract

In a prospective study of 41 persons with ocular hypertension followed for 20 years, 14 individuals (34 per cent) developed glaucoma. Of 38 persons who 20 years ago were normotensive, 2 (5 per cent), developed glaucoma. This difference is significant. The mean IOP of the remaining untreated ocular hypertensives was about 7 mmHg higher than the mean tension in the control group.

Entities:  

Mesh：

Year:  1987        PMID： 3434236     DOI： 10.1111/j.1755-3768.1987.tb07067.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN： 0001-639X


  9 in total

Review 1.  Spatial proteomics: a powerful discovery tool for cell biology.

Authors:  Emma Lundberg; Georg H H Borner
Journal:  Nat Rev Mol Cell Biol       Date:  2019-05       Impact factor: 94.444

2.  Optic disc pallor and visual field defect in exfoliative and non-exfoliative, untreated ocular hypertension.

Authors:  E Linnér; B Schwartz; D Araujo
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

3.  Management and diagnosis of glaucoma for the family physician.

Authors:  I A Chisholm
Journal:  Can Fam Physician       Date:  1990-04       Impact factor: 3.275

4.  Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Authors:  M A Kass
Journal:  Trans Am Ophthalmol Soc       Date:  1989

5.  Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Authors:  A Hommer; B Kapik; N Shams
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

6.  Optic nerve head circulation in untreated ocular hypertension.

Authors:  G T Feke; B Schwartz; T Takamoto; N Fujio; S Konno; D G Goger; V Nangia
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

7.  Longitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment.

Authors:  Eleonore Savatovsky; Jean-Claude Mwanza; Donald L Budenz; William J Feuer; Ruth Vandenbroucke; Joyce C Schiffman; Douglas R Anderson
Journal:  Ophthalmology       Date:  2014-09-07       Impact factor: 12.079

8.  Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Richard K Parrish; Cheryl L Khanna; James D Brandt; Joern B Soltau; Chris A Johnson; John L Keltner; Julia B Huecker; Bradley S Wilson; Lei Liu; J Phillip Miller; Harry A Quigley; Mae O Gordon
Journal:  JAMA Ophthalmol       Date:  2021-04-15       Impact factor: 8.253

Review 9.  Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma.

Authors:  Pawel Grieb; Anselm Jünemann; Marek Rekas; Robert Rejdak
Journal:  Front Aging Neurosci       Date:  2016-04-08       Impact factor: 5.750
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.